NUWE

Nuwellis Inc

0.9773

Aug 25 • 2:45 PM ET -0.0727 (-6.92%)

Healthcare Medical Devices USA Nano NASD

Today, 9:05 AMNuwellis, Atrility Medical sign FDA-cleared AtriAmp co-promotion and distribution pact with 6-month pilot for potential exclusive U.S. distribution

Peers: VTAK NVNO HSCS ICCM TNON MYO LFWD IRIX XAIR AEMD

Scroll to Statements

Index	-
Market Cap	3.56M
Enterprise Value	-0.15M
Income	-11.32M
Sales	9.01M
Book/sh	-3.58
Cash/sh	1.07
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	38
IPO	Feb 16, 2012

P/E	-
Forward P/E	-
PEG	-
P/S	0.40
P/B	-
P/C	0.91
P/FCF	-
EV/EBITDA	-
EV/Sales	-0.02
Quick Ratio	1.54
Current Ratio	1.97
Debt/Eq	-
LT Debt/Eq	-
Option/Short	No / No

EPS (ttm)	-136.06
EPS next Y	-
EPS next Q	-
EPS this Y	-
EPS next Y	-
EPS next 5Y	-
EPS past 3/5Y	94.09% 88.99%
Sales past 3/5Y	-1.08% 2.14%
EPS Y/Y TTM	88.88%
Sales Y/Y TTM	8.36%
EPS Q/Q	98.75%
Sales Q/Q	14.14%
Earnings	Aug 13 BMO
EPS/Sales Surpr.	- -

Insider Own	18.00%
Insider Trans	0.00%
Inst Own	2.59%
Inst Trans	7.16%
ROA	-123.57%
ROE	-609.44%
ROIC	-
Gross Margin	69.69%
Oper. Margin	-142.87%
Profit Margin	-125.57%
SMA20	-37.45%
SMA50	-61.99%
SMA200	-97.83%
Trades

Shs Outstand	3.65M
Shs Float	2.99M
Short Float	31.95%
Short Ratio	0.32
Short Interest	0.96M
52W High	187.60 -99.48%
52W Low	1.05 -6.92%
Volatility	10.42% 15.12%
ATR (14)	0.40
RSI (14)	30.61
Beta	0.26
Rel Volume	0.23
Avg Volume	2.99M
Volume	551,013

Perf Week	-17.87%
Perf Month	-50.89%
Perf Quarter	-96.92%
Perf Half Y	-98.27%
Perf YTD	-98.40%
Perf Year	-99.47%
Perf 3Y	-100.00%
Perf 5Y	-100.00%
Perf 10Y	-100.00%
Recom	1.00
Target Price	16170.00
Prev Close	1.05
Price	0.98
Change %	-6.92%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-29-24	Initiated	ROTH MKM	Buy	$17

Today 08:30AM	Nuwellis Expands Critical Care Portfolio Through Strategic Commercial Agreement with Atrility Medical (GlobeNewswire) -6.92%
Aug-13-26 07:05PM	Nuwellis Inc (NUWE) (Q2 2026) Earnings Call Highlights: Revenue Surges 14% and Installed Base ... (GuruFocus.com) -7.80%
08:00AM	Nuwellis Reports Second Quarter 2026 Financial Results and Business Highlights Focused on Double Digit Revenue Growth and Expanded Gross Margin (GlobeNewswire)
Aug-11-26 03:30AM	Nuwellis Accelerates Digital Transformation of the Aquadex Platform with EHR Connectivity and Enhanced User Interface (GlobeNewswire)
Aug-06-26 08:30AM	Nuwellis Strengthens Product Development Organization with Appointment of Dale Brady as Principal R&D Engineer (GlobeNewswire)
08:30AM	Loading…
Aug-04-26 08:30AM	Nuwellis Announces Next-Generation Aquadex Platform Strategy to Expand Future Critical Care Applications (GlobeNewswire) +16.77%
Jul-31-26 08:39AM	Nuwellis Announces Pricing of $3.4 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules (GlobeNewswire) -60.90%
Jul-30-26 08:00AM	Nuwellis Announces Acceptance by Frontiers in Pediatrics of New Single-Center Retrospective Study Supporting Alternative Anticoagulation Strategy for Aquadex Ultrafiltration Therapy (GlobeNewswire) +135.45%
Jul-28-26 08:00AM	Nuwellis Expands Pediatric Footprint with First Aquadex SmartFlow Installations in Wisconsin (GlobeNewswire)
Jul-27-26 08:30AM	Nuwellis Announces Preliminary Revenue Results for the Second Quarter 2026 Showing Double Digit Growth (GlobeNewswire)
08:11AM	Nuwellis new CEO on building a strong foundation for sustainable value creation (Medical Device Network)
Jul-16-26 08:30AM	Nuwellis Awarded U.S. Patent for Novel Catheter Technology Designed to Enhance Extracorporeal Therapies (GlobeNewswire) -5.77%
Jul-07-26 08:00AM	Nuwellis to Showcase Aquadex Therapy at KidneyBee Summit 2026 (GlobeNewswire)
Jun-26-26 08:00AM	Nuwellis Celebrates Five Years of Support of the Pediatric Cardiac Critical Care Consortium (PC4) (GlobeNewswire)
Jun-25-26 08:30AM	Nuwellis Announces Pediatric Expansion in Michigan with First Aquadex SmartFlow Installations (GlobeNewswire) +6.29%
08:30AM	Loading…
Jun-24-26 08:30AM	Incoming Nuwellis CEO Mike McCormick Underscores Strategic Priorities for Continued Market Expansion in Pediatric Category and Revenue Generation in Letter to Shareholders (GlobeNewswire) -30.47%
Jun-18-26 08:30AM	Nuwellis Expands Critical Care Education with Aquadex Training at University of Minnesota Critical Care Cardiology Education Summit (GlobeNewswire)
Jun-16-26 08:30AM	Nuwellis Appoints Mike McCormick as Chief Executive Officer (GlobeNewswire)
Jun-10-26 08:30AM	Nuwellis Expands Collaboration with Major South Carolina Healthcare System to Install New Aquadex SmartFlow Devices at One of its Children's Hospitals (GlobeNewswire)
Jun-08-26 09:46PM	Nuwellis Announces Closing of $6.0 Million Registered Public Offering (GlobeNewswire) -13.28%
Jun-05-26 10:29AM	Nuwellis Shares Sink After Pricing $6 Million Equity and Warrant Offering (NUWE) (InvestorsHub) -61.21%
08:30AM	Nuwellis Announces Pricing of $6 Million Public Offering (GlobeNewswire)
May-14-26 08:30AM	Nuwellis Announces Successful Completion of FDA Pre-Submission 510(k) Meeting to Expand Aquadex Label (GlobeNewswire)
May-12-26 07:01PM	Nuwellis Inc (NUWE) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
01:19PM	Nuwellis, Inc. Q1 2026 Earnings Call Summary (Moby)
08:00AM	Nuwellis, Inc. Announces First Quarter 2026 Financial Results (GlobeNewswire)
May-05-26 08:00AM	Nuwellis, Inc. To Announce First Quarter 2026 Financial Results on May 12, 2026 (GlobeNewswire)
Apr-29-26 08:30AM	Nuwellis Highlights Case Study Featuring Precision Ultrafiltration Therapy in Pediatric Cardiorenal Care at ISHLT 2026 Annual Meeting (GlobeNewswire)
Apr-28-26 08:30AM	Nuwellis Announces Receipt of a Notice of Allowance from the U.S. Patent and Trademark Office for Innovative Dual Lumen Midline Catheter Technology (GlobeNewswire)
Apr-23-26 08:30AM	Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat (GlobeNewswire)
08:30AM	Loading…
Apr-21-26 08:30AM	Nuwellis Announces Aquadex Software Update (GlobeNewswire)
Apr-16-26 08:30AM	Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum (GlobeNewswire)
Apr-09-26 08:30AM	Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services (GlobeNewswire)
Apr-07-26 08:30AM	Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory (GlobeNewswire)
Mar-31-26 08:30AM	Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone (GlobeNewswire)
Mar-17-26 08:00AM	Nuwellis Completes Acquisition of Rendiatech (GlobeNewswire) -8.47%
Mar-10-26 12:43PM	Nuwellis, Inc. Q4 2025 Earnings Call Summary (Moby)
08:15AM	Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-05-26 08:00AM	Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy (GlobeNewswire) -5.13%
Feb-26-26 08:00AM	Nuwellis Appoints David A. McDonald and Martin J. Emerson to Board of Directors (GlobeNewswire)
Feb-24-26 08:00AM	Nuwellis, Inc. To Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026 (GlobeNewswire)
Jan-30-26 08:00AM	Nuwellis Appoints Carisa Schultz as Chief Financial Officer (GlobeNewswire) -10.02%
Jan-29-26 04:36PM	Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market (GlobeNewswire) +8.55%
04:35PM	Nuwellis Enters into Definitive Agreement to Acquire Rendiatech, Advancing Its Cardiorenal Portfolio Strategy (GlobeNewswire)
Jan-27-26 11:14AM	Nuwellis Stock Surges 100% As $2 Microcap Beats Big Pharma In Infant Healthcare (Benzinga) +78.14%
Jan-23-26 04:40PM	Nuwellis Announces Changes to Board of Directors (GlobeNewswire)
Jan-06-26 08:15AM	Nuwellis Announces Issuance of New U.S. Patent Supporting Advanced Safety Design for Pediatric Extracorporeal Therapy (GlobeNewswire)
Dec-09-25 08:15AM	Lenox Hill Hospital Study Highlights the Broad Utility of Aquadex in Managing Fluid Overload Across Critical Care Settings (GlobeNewswire)
Dec-04-25 08:15AM	Nuwellis Continues Clinician-Driven Growth in Pediatric Care with a Leading Hospital in the Northeast U.S. (GlobeNewswire) +12.39%
Nov-12-25 04:03PM	Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ... (GuruFocus.com) -8.43%
08:15AM	Nuwellis Reports Third Quarter 2025 Results and Continued Operational Momentum (GlobeNewswire)
Nov-10-25 09:00AM	Nuwellis Receives Notice of Allowance of a New U.S. Patent Strengthening Vivian Pediatric System with Advanced Clamp Safety Technology (GlobeNewswire) -5.57%
Oct-23-25 09:00AM	Nuwellis, Inc. To Report Third Quarter 2025 Financial Results on November 12, 2025 (GlobeNewswire)
Sep-30-25 08:45AM	Nuwellis Announces 92% Survival in Children with Acute Kidney Injury (AKI), Fluid Overload or Congenital Kidney Failure Following Treatment with Aquadex (GlobeNewswire) -5.10%
Sep-18-25 09:00AM	Nuwellis Receives New US Patent Reinforcing Vivian Pediatric Device Focused on Safer, More Precise Ultrafiltration (GlobeNewswire)
Sep-17-25 10:16AM	Nuwellis, Inc. Participates in a Virtual Investor "What This Means" Segment (GlobeNewswire)
Sep-09-25 09:00AM	Nuwellis' Vivian Receives $3 Million NIH Grant to Accelerate Pediatric Platform and Strengthen Fluid-Management Portfolio (GlobeNewswire) -9.01%
Sep-04-25 08:15AM	Nuwellis Introduces New 24-Hour Aquadex Circuit to Support Hospital-Based Outpatient and Short-Term Fluid Management (GlobeNewswire)
Aug-21-25 08:15AM	Nuwellis Receives FDA 510(k) Clearance for New Dual Lumen Extended Length Catheter (GlobeNewswire)
Aug-19-25 08:15AM	Nuwellis Signs Letter of Intent to Explore Acquisition of Rendiatech Ltd., A Real-Time Fluid Monitoring Company (GlobeNewswire) -5.40%
Aug-15-25 08:15AM	Nuwellis, Inc. to Present at the Webull Financial Corporate Connect Webinar Series: Biotech/MedTech (GlobeNewswire)
03:17AM	Nuwellis Inc (NUWE) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Challenges (GuruFocus.com)
Aug-14-25 08:15AM	Nuwellis, Inc. Reports Second Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
Aug-07-25 08:15AM	Nuwellis to Exit International Operations to Accelerate U.S. Revenue Growth and Strategic Focus (GlobeNewswire)
Aug-06-25 08:15AM	Nuwellis Postpones Second Quarter 2025 Earnings Release and Conference Call to August 14, 2025 (GlobeNewswire)
Aug-05-25 08:15AM	Nuwellis Announces the First Successful Outpatient Application of the Aquadex Smartflow System Under New CMS Code (GlobeNewswire) -21.18%
Aug-04-25 05:24PM	Nuwellis Stockholders Approve All Proposals at Special Meeting (GlobeNewswire) -27.36%
Jul-23-25 08:45AM	Nuwellis Participates in the Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference (GlobeNewswire)
08:15AM	Nuwellis Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Jul-22-25 08:40AM	JTC Team Virtual Investor "What's Your Story" Summer Spotlight On-Demand Conference Now Live (ACCESSWIRE)
08:15AM	Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025 (GlobeNewswire)
Jul-17-25 07:35AM	Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care (GlobeNewswire)
Jul-16-25 10:30AM	BC-Most Active Stocks (Associated Press Finance) +131.33%
Jul-15-25 04:05PM	Nuwellis Secures New U.S. Patent, Strengthening Its Position as a Leader in Fluid Management Innovation (GlobeNewswire) -11.72%
Jul-02-25 08:15AM	Nuwellis Appoints John Erb as Chief Executive Officer (GlobeNewswire) -5.10%
Jun-10-25 04:15PM	Nuwellis Announces Closing of $5.0 Million Underwritten Public Offering Including Full Exercise of Overallotment Option (GlobeNewswire) +57.56%
09:20AM	Nuwellis announces pricing of $4.3M underwritten public offering (TipRanks)
Jun-09-25 09:15AM	Nuwellis Announces Pricing of $4.3 Million Underwritten Public Offering (GlobeNewswire) -42.94%
May-14-25 03:10AM	Nuwellis Inc (NUWE) Q1 2025 Earnings Call Highlights: Strategic Growth Amidst Operational Challenges (GuruFocus.com)
May-13-25 08:15AM	Nuwellis, Inc. (NUWE) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
07:00AM	Nuwellis, Inc. Reports First Quarter 2025 Financial Results and Business Highlights (GlobeNewswire)
May-12-25 07:00AM	Nuwellis Contracts with KDI Precision Manufacturing to Strengthen Production and Improve Operational Efficiency (GlobeNewswire)
May-08-25 06:35PM	CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
07:00AM	Nuwellis Expands Aquadex for Pediatric Fluid Management to Two New Hospital Systems (GlobeNewswire)
Apr-30-25 05:50PM	Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
Apr-24-25 07:00AM	Nuwellis Expands IP Portfolio with Patent That Reduces Clinical Burden, Preserves Precision (GlobeNewswire) +7.24%
Apr-22-25 04:05PM	Nuwellis, Inc. To Report First Quarter 2025 Financial Results on May 13, 2025 (GlobeNewswire)
Apr-21-25 05:02PM	Nuwellis Inc (NUWE) Q4 2024 Earnings Call Highlights: Navigating Revenue Challenges with ... (GuruFocus.com)
Mar-11-25 08:00AM	Nuwellis, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-24-25 04:05PM	Nuwellis Announces Retirement of Nestor Jaramillo, Jr. as President and CEO (GlobeNewswire) -5.56%
Feb-20-25 08:00AM	JACC: Heart Failure Paper Reports Promising Findings of Aquadex Therapy in Updated AVOID-HF Study Analysis (GlobeNewswire) -6.85%
Feb-18-25 04:15PM	Nuwellis, Inc. To Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025 (GlobeNewswire) +11.45%
Jan-13-25 08:00AM	Nuwellis Adds Nationally Ranked Utah Hospital as New Pediatric Customer for Aquadex SmartFlow Therapy (GlobeNewswire)
Dec-19-24 09:00AM	Nuwellis Regains Compliance with Nasdaq Listing Requirements (GlobeNewswire)
Nov-11-24 08:00AM	Nuwellis, Inc. Announces Third Quarter 2024 Financial Results and Recent Highlights (GlobeNewswire) +13.26%
Nov-05-24 09:28AM	Nuwellis Announces Exercise of Warrants for $5.1 Million of Gross Proceeds (GlobeNewswire) -34.52%
Nov-04-24 01:43PM	Nuwellis Stock Soars 121% on Major Increase in Reimbursement for Aquadex System (GuruFocus.com) +106.62%
08:30AM	Nuwellis Receives Increased Reimbursement Rate for Aquadex SmartFlow Therapy from the Centers for Medicare and Medicaid (GlobeNewswire)
Nov-01-24 04:15PM	Nuwellis Announces Preliminary Results for Third Quarter of 2024 (GlobeNewswire) -20.93%
Oct-31-24 08:00AM	Nuwellis Welcomes University of Iowa Health Care Stead Family Children's Hospital as Newest Pediatric Customer (GlobeNewswire) -11.79%

Nuwellis, Inc. operates as a medical device company. It engages in the provision of products for the treatment of fluid overload. The firm's products include Aquadex FlexFlow System, which provides an ultrafiltration for the removal of salt and water in patients with hypervolemia, or fluid overload. It operates through Cardiac and Coronary Disease Products segment. The company was founded by Crispin Marsh and William S. Peters in November 1999 and is headquartered in Eden Prairie, MN.

PresidentMr. Michael Kendrick McCormick

Senior VPMr. Neil P. Ayotte Esq.

CFOMs. Carisa Schultz

Chief Technology OfficerMr. David Lerner

Director of CommunicationsLeah McMullen

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NUWE

Nuwellis Inc

Upgrade your Finviz experience